Login / Signup

Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats.

Margaret E GruenJamie A E MyersJezaniah-Kira S TenaCsilla BecskeiDawn M CleaverBenedict Duncan X Lascelles
Published in: Journal of veterinary internal medicine (2021)
Frunevetmab has the potential to address a critical gap in the treatment of pain because of osteoarthritis in cats.
Keyphrases
  • growth factor
  • monoclonal antibody
  • chronic pain
  • rheumatoid arthritis
  • pain management
  • neuropathic pain
  • climate change